HealthcareModerna slips to bottom of S&P 500 amid mixed sentimentJan. 29, 2022 12:00 PM ETModerna, Inc. (MRNA) StockPFE, BNTXBy: Dulan Lokuwithana, SA News Editor34 Comments Maddie Meyer/Getty Images News In solidarity with the selloff in the biotech space, Moderna (NASDAQ:MRNA) has lost more than 41% YTD, becoming the sharpest decliner in the S&P 500, notwithstanding a promising preannouncement on 2022 COVID-19 vaccine sales issuedRecommended For YouAbout MRNA StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgMRNA--Moderna, Inc.Trending AnalysisTrending News
